Human herpesvirus 8 viral interleukin-6 interacts with splice variant 2 of vitamin K epoxide reductase complex subunit 1

Journal of Virology

Volumn 86, Issue 3, 2012, Pages 1577-1588

  Chen, Daming ^a   Cousins, Emily ^a   Sandford, Gordon ^a   Nicholas, John ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; MENADIONE EPOXIDE; UNCLASSIFIED DRUG; VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CELLULAR DISTRIBUTION; CYTOKINE RELEASE; ENDOPLASMIC RETICULUM; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELL LINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HERPESVIRUS 8, HUMAN; HUMANS; INTERLEUKIN-6; MICROSCOPY, FLUORESCENCE; MIXED FUNCTION OXYGENASES; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RNA SPLICING; TWO-HYBRID SYSTEM TECHNIQUES;

HUMAN HERPESVIRUS 8;

EID: 84863116455     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05782-11     Document Type: Article

References (25)

1. Adam N, et al. 2009. Unraveling viral interleukin-6 binding to gp130 and activation of STAT-signaling pathways independently of the interleukin-6 receptor. J. Virol. 83:5117-5126.
2. Cain D, Hutson SM, Wallin R. 1997. Assembly of the warfarin-sensitive vitamin K 2,3-epoxide reductase enzyme complex in the endoplasmic reticulum membrane. J. Biol. Chem. 272:29068-29075.
3. Chen D, Choi YB, Sandford G, Nicholas J. 2009. Determinants of secretion and intracellular localization of human herpesvirus 8 interleukin-6. J. Virol. 83:6874-6882.
4. Chen D, Nicholas J. 2006. Structural requirements for gp80 independence of human herpesvirus 8 interleukin-6 (vIL-6) and evidence for gp80 stabilization of gp130 signaling complexes induced by vIL-6. J. Virol. 80: 9811-9821.
5. Chen D, Sandford G, Nicholas J. 2009. Intracellular signaling mechanisms and activities of human herpesvirus 8 interleukin-6. J. Virol. 83: 722-733.
6. Chow DC, et al. 2002. A structural template for gp130-cytokine signaling assemblies. Biochim. Biophys. Acta 1592:225-235.
7. Dayel MJ, Hom EF, Verkman AS. 1999. Diffusion of green fluorescent protein in the aqueous-phase lumen of endoplasmic reticulum. Biophys. J. 76:2843-2851.
8. Fliegel L, Burns K, MacLennan DH, Reithmeier RA, Michalak M. 1989. Molecular cloning of the high affinity calcium-binding protein (calreticulin) of skeletal muscle sarcoplasmic reticulum. J. Biol. Chem. 264: 21522-21528.
9. Gasperini P, Sakakibara S, Tosato G. 2008. Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesis. J. Leukoc. Biol. 84:994-1000.
10. Helenius A, Aebi M. 2001. Intracellular functions of N-linked glycans. Science 291:2364-2369.
11. Li H, Wang H, Nicholas J. 2001. Detection of direct binding of human herpesvirus 8-encoded interleukin-6 (vIL-6) to both gp130 and IL-6 receptor (IL-6R) and identification of amino acid residues of vIL-6 important for IL-6R-dependent and -independent signaling. J. Virol. 75: 3325-3334.
12. Meads MB, Medveczky PG. 2004. Kaposi's sarcoma-associated herpesvirus-encoded viral interleukin-6 is secreted and modified differently than human interleukin-6: evidence for a unique autocrine signaling mechanism. J. Biol. Chem. 279:51793-51803.
13. Miles SA, et al. 1990. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc. Natl. Acad. Sci. U. S. A. 87:4068-4072.
14. Molden J, Chang Y, You Y, Moore PS, Goldsmith MA. 1997. A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J. Biol. Chem. 272:19625-19631.
15. Moore PS, Boshoff C, Weiss RA, Chang Y. 1996. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274:1739-1744.
16. Mullberg J, et al. 2000. IL-6 receptor independent stimulation of human gp130 by viral IL-6. J. Immunol. 164:4672-4677.
17. Nicholas J, et al. 1997. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat. Med. 3:287-292.
18. Oldenburg J, Bevans CG, Muller CR, Watzka M. 2006. Vitamin K epoxide reductase complex subunit 1 (VKORC1): the key protein of the vitamin K cycle. Antioxid. Redox Signal. 8:347-353.
19. Rost S, et al. 2004. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 427:537-541.
20. Schulman S, Wang B, Li W, Rapoport TA. 2010. Vitamin K epoxide reductase prefers ER membrane-anchored thioredoxin-like redox partners. Proc. Natl. Acad. Sci. U. S. A. 107:15027-15032.
21. Tie JK, Nicchitta C, von Heijne G, Stafford DW. 2005. Membrane topology mapping of vitamin K epoxide reductase by in vitro translation/cotranslocation. J. Biol. Chem. 280:16410-16416.
22. Wada I, et al. 1991. SSR alpha and associated calnexin are major calcium binding proteins of the endoplasmic reticulum membrane. J. Biol. Chem. 266:19599-19610.
23. Wajih N, Hutson SM, Wallin R. 2007. Disulfide-dependent protein folding is linked to operation of the vitamin K cycle in the endoplasmic reticulum. A protein disulfide isomerase-VKORC1 redox enzyme complex appears to be responsible for vitamin K1 2,3-epoxide reduction. J. Biol. Chem. 282:2626-2635.
24. Wan X, Wang H, Nicholas J. 1999. Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6. J. Virol. 73:8268-8278.
25. Yoshizaki K, et al. 1989. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 74:1360-1367.